Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 91Stomach Neoplasms 44Pancreatic Neoplasms 37Rectal Neoplasms 29Colonic Neoplasms 23Neoplasms 22Esophageal Neoplasms 21Squamous Cell Carcinoma of Head and Neck 20Neoplasm Metastasis 18Cholangiocarcinoma 16Adenocarcinoma Of Esophagus 16Biliary Tract Neoplasms 13Parkinson Disease 4, Autosomal Dominant Lewy Body 12Head and Neck Neoplasms 12Esophageal Squamous Cell Carcinoma 12Carcinoma, Non-Small-Cell Lung 12Adenocarcinoma 12Urinary Bladder Neoplasms 11Ovarian Neoplasms 9Gastrointestinal Neoplasms 9Carcinoma, Hepatocellular 7Endometrial Neoplasms 6Breast Neoplasms 6Gallbladder Neoplasms 5Advanced Solid Tumors 5Uterine Cervical Neoplasms 4Peritoneal Neoplasms 4Lung Neoplasms 4Carcinoma 4Appendiceal Neoplasms 4

Interventions

pembrolizumab 3Ribavirin 1Injections 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Fluorouracil × 1 year × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡